Clinical trial
Audit of the Effect of Changing From IV to SC Administration of ESA's in…
NCT00382044 · Sir Charles Gairdner Hospital, Other · Completed
Key facts
| NCT number | NCT00382044 |
|---|---|
| Title | Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients |
| Official title | Audit of the Effect of Changing From IV to SC Administration of Erythropoiesis Stimulating Agents in Haemodialysis Patients - Real Life Clinical Experience |
| Lead sponsor | Sir Charles Gairdner Hospital, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Kidney Failure, Chronic, Anemia |
| Intervention type | Drug |
| Interventions | Eprex, Neorecormon, Aranesp |
| Enrollment | 150 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Sep 28, 2006 |
| Last update posted | May 23, 2008 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: